Beta-2 microglobulin is important for disease progression in a murine model for amyotrophic lateral sclerosis

被引:20
|
作者
Staats, Kim A. [1 ,2 ,3 ,4 ,5 ]
Schonefeldt, Susann [4 ,5 ]
Van Rillaer, Marike [4 ,5 ]
Van Hoecke, Annelies [1 ,2 ,3 ]
Van Damme, Philip [1 ,2 ,3 ,6 ]
Robberecht, Wim [1 ,2 ,3 ,6 ]
Liston, Adrian [4 ,5 ]
Van Den Bosch, Ludo [1 ,2 ,3 ]
机构
[1] Katholieke Univ Leuven, Lab Neurobiol, B-3000 Louvain, Belgium
[2] Leuven Res Inst Neurosci & Dis LIND, Louvain, Belgium
[3] Katholieke Univ Leuven, VIB Vesalius Res Ctr, B-3000 Louvain, Belgium
[4] Katholieke Univ Leuven, VIB Autoimmune Genet Lab, B-3000 Louvain, Belgium
[5] Katholieke Univ Leuven, Dept Microbiol & Immunol, Louvain, Belgium
[6] Katholieke Univ Leuven Hosp, Louvain, Belgium
关键词
beta-2; microglobulin; amyotrophic lateral sclerosis; motor neuron; neurodegeneration; motor neuron disease; MHC CLASS-I; MICE; MOTONEURONS; EXPRESSION; MOLECULES; GAMMA; BETA(2)-MICROGLOBULIN; NEUROPROTECTION; REGENERATION; DEFICIENT;
D O I
10.3389/fncel.2013.00249
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Beta-2 microglobulin (beta 2m) is an essential component of the major histocompatibility complex (MHC) class I proteins and in the nervous system beta 2m is predominantly expressed in motor neurons. As beta 2m can promote nerve regeneration, we investigated its potential role in amyotrophic lateral sclerosis (ALS) by investigating its expression level as well as the effect of genetically removing beta 2m on the disease process in mutant superoxide dismutase 1 (SOD1(G93A)) mice, a model of ALS. We observed a strong upregulation of beta 2m in motor neurons during the disease process and ubiquitous removal of beta 2m dramatically shortens the disease duration indicating that beta 2m plays an essential and positive role during the disease process. We hypothesize that beta 2m contributes to plasticity that is essential for muscle reinnervation. Absence of this plasticity will lead to faster muscle denervation and counteracting this process could be a relevant therapeutic target.
引用
收藏
页数:5
相关论文
共 50 条
  • [1] Amyotrophic lateral sclerosis disease progression model
    Gomeni, Roberto
    Fava, Maurizio
    [J]. AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 2014, 15 (1-2) : 119 - 129
  • [2] Relationship between Liver Pathology and Disease Progression in a Murine Model of Amyotrophic Lateral Sclerosis
    Lee, Sun Hwa
    Yang, Eun Jin
    [J]. NEURODEGENERATIVE DISEASES, 2018, 18 (04) : 200 - 207
  • [3] Beta-2 microglobulin and neopterin as markers of disease activity in multiple sclerosis
    Bagnato, F
    Durastanti, V
    Finamore, L
    Volante, G
    Millefiorini, E
    [J]. NEUROLOGICAL SCIENCES, 2003, 24 (Suppl 5) : S301 - S304
  • [4] Beta-2 microglobulin and neopterin as markers of disease activity in multiple sclerosis
    F. Bagnato
    V. Durastanti
    L. Finamore
    G. Volante
    E. Millefiorini
    [J]. Neurological Sciences, 2003, 24 : s301 - s304
  • [5] Immune reactivity mouse model of amyotrophic lateral sclerosis and amyotrophic lateral sclerosis progression
    Fedotova, I
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2004, 154 (1-2) : 172 - 172
  • [6] Amyotrophic Lateral Sclerosis: A Focus on Disease Progression
    Calvo, Ana C.
    Manzano, Raquel
    Mendonca, Deise M. F.
    Munoz, Maria J.
    Zaragoza, Pilar
    Osta, Rosario
    [J]. BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [7] Predictability of disease progression in amyotrophic lateral sclerosis
    Czaplinski, A.
    Yen, A.
    Simpson, E. P.
    Appel, S. H.
    [J]. JOURNAL OF NEUROLOGY, 2006, 253 : 30 - 30
  • [8] Predicting disease progression in amyotrophic lateral sclerosis
    Taylor, Albert A.
    Fournier, Christina
    Polak, Meraida
    Wang, Liuxia
    Zach, Neta
    Keymer, Mike
    Glass, Jonathan D.
    Ennist, David L.
    [J]. ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2016, 3 (11): : 866 - 875
  • [9] Predictability of disease progression in amyotrophic lateral sclerosis
    Czaplinski, Adam
    Yen, Albert A.
    Simpson, Ericka P.
    Appel, Stanley H.
    [J]. MUSCLE & NERVE, 2006, 34 (06) : 702 - 708
  • [10] Quantifying Disease Progression in Amyotrophic Lateral Sclerosis
    Simon, Neil G.
    Turner, Martin R.
    Vucic, Steve
    Al-Chalabi, Ammar
    Shefner, Jeremy
    Lomen-Hoerth, Catherine
    Kiernan, Matthew C.
    [J]. ANNALS OF NEUROLOGY, 2014, 76 (05) : 643 - 657